BioHitech America

BioHitech America

BioHitech America is a family office established to manage the private holdings of the founder of BioHiTech Global, a firm that commercialized the HAT (High-solids Anaerobic Treatment) digestion system. The office's wealth originates from the development and sale of waste processing technologies. The firm concentrates on waste-to-energy and clean technology investments, targeting anaerobic digestion, aerobic composting, and related infrastructure. BioHitech America has deployed capital into operational projects such as the Meadowlands Biogas Facility in New Jersey, which processes over 100,000 tons of food waste annually (per the firm's project disclosures). Geographically, the firm focuses on the United States, particularly the Northeast and Mid-Atlantic regions, with additional interests in European markets. BioHitech America has operated as a single family office since its founding, with a small team of professionals based in Chestnut Ridge. The firm supports related entities including BioHiTech Global, which was listed on the Nasdaq until its acquisition by a special purpose acquisition company in 2022 (per SEC filings). The office also manages a portfolio of renewable energy facilities and real estate assets. The firm's structural differentiator lies in its exclusive focus on the waste-to-energy sector—a narrow vertical that most family offices avoid. This single-thesis approach allows BioHitech America to provide operational expertise and co-investment alongside project developers in capital-intensive waste infrastructure.